Add time:09/30/2019 Source:infona.pl
Polymeric prodrugs of N,N-di(2-chloroethyl)-4-phenylenediamine mustard (PDM) were prepared by coupling the drug via an oligopeptide spacer onto poly[N 5 -(2-hydroxyethyl)-l-glutamine] (PHEG). In a first step PDM was linked to the peptide spacer and subsequently the low molecular weight peptidyl-PDM derivatives were coupled to 4-nitrophenyl chloroformate activated PHEG. Hydrolytic stability studies clearly demonstrated an improved stability for the polymeric derivatives compared to the parent drug. Dynamic laser light scattering measurements indicated the formation of aggregates. The influence of the amino acid sequence of the spacer on the enzymatic stability of the macromolecular drug conjugate was investigated under different conditions. Accordingly, the conjugates were incubated in buffers of lysosomal or physiological pH and in the presence of lysosomal or tumor-associated enzymes. The gly-phe-ala-leu based derivative proved to be a promising candidate for further biological evaluations.
We also recommend Trading Suppliers and Manufacturers of 2-Chloroethyl Chloroformate (cas 27-11-2). Pls Click Website Link as below: cas 27-11-2 suppliers
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View